Overview
aPTT measures clotting time after contact activation of citrate plasma with a partial thromboplastin reagent and calcium.
Clinical Importance
To screen intrinsic/common pathway abnormalities and inhibitors
To monitor unfractionated heparin where aPTT-based protocols are validated
Specimen Requirements
- Specimen: platelet-poor plasma prepared from whole blood
- Tube: light-blue top; 3.2% sodium citrate (0.109 mol/L)
- Anticoagulant ratio: 9:1 blood-to-citrate (CLSI H21); fill to the tube fill line
- Handling: invert gently; transport promptly; avoid traumatic draws and line heparin contamination
- Processing: centrifuge to platelet-poor plasma per institutional protocol before testing
- Stability: assay-specific (CLSI H21). aPTT is generally less stable than PT; do not exceed validated time/temperature limits for the ordered tests.
Analytical Method
Contact activator + phospholipid reagent triggers the intrinsic pathway; time to fibrin clot is recorded.
Instruments Used
Automated analyzers
- Sysmex CS / CN coagulation analyzers
- Werfen / Instrumentation Laboratory ACL TOP coagulation analyzers
- Siemens Healthineers BCS coagulation analyzers
- Stago STA Compact / STA R Max coagulation analyzers
Manual methods
- Manual tilt-tube clotting methods (selected reference/backup contexts)
Reference Values
Typical adult SI examples below follow widely published international hematology practice (e.g., Dacie and Lewis; Henry's). Always interpret against the method- and demographics-specific interval printed on the patient report (CLSI EP28-A3c). Neonatal, pediatric, pregnancy, and altitude intervals differ.
Example adult aPTT intervals are reagent-specific (commonly about 25 to 35 seconds on many systems). Always use the local interval.
Unfractionated heparin therapeutic aPTT ranges are protocol- and reagent-specific, not universal.
Interpretation
Critical and significant-risk limits are institution-defined (CLSI GP47). Confirm the local call list. Textbook examples are not universal thresholds.
Critical values
- Markedly prolonged aPTT may be critical per policy, especially on heparin protocols
Common Causes of Increased Results
- Prolonged aPTT: heparin, intrinsic factor deficiencies, lupus anticoagulant, contact factor deficiency, or artifact
Common Causes of Decreased Results
- Short aPTT may reflect elevated factor VIII or activation artifact; clinical significance varies
Clinical Significance
- Hemostasis screening with PT
- Unfractionated heparin monitoring when locally validated
- Entry point to mixing studies and inhibitor workups
Factors Affecting Results
Pre-analytical
- Underfilled citrate tube (excess anticoagulant prolongs clotting times)
- Overfilled tube or clot in specimen
- Hematocrit >55% may require adjusted citrate volume (CLSI H21 guidance)
- Delayed processing or improper storage beyond assay stability
- Heparin contamination from line draws
Analytical
- Reagent lot / instrument calibration differences
- Lipemia, hemolysis, or icterus interfering with photo-optical endpoints
Post-analytical
- Applying another laboratory's reference interval
- Misreading INR therapeutic targets as untreated reference intervals
Advantages and Limitations
Advantages
- Sensitive screen for many intrinsic pathway issues
- Widely available
Limitations
- Reagent responsiveness to heparin and lupus anticoagulant varies
- Normal aPTT does not exclude all bleeding disorders
Clinical Pearls
A prolonged aPTT with no bleeding history often leads to lupus anticoagulant testing; clinical history guides the next assay.
References
Authoritative textbooks, guidelines, and reviews supporting this laboratory test reference. Verify reference intervals, critical limits, and method details against institutional protocols and current guideline editions.
Textbooks
- McPherson RA, Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 24th ed. Elsevier; 2021.
- Rodak BF, Carr JH. Rodak's Hematology: Clinical Principles and Applications. 6th ed. Elsevier; 2020.
- Hoffbrand AV, Moss PAH, Pettit JE. Essential Haematology. 8th ed. Wiley-Blackwell; 2019.
- McKenzie SB, Williams JL. Clinical Laboratory Hematology. 4th ed. Pearson; 2022.
- Bain BJ, Bates I, Laffan MA. Dacie and Lewis Practical Haematology. 12th ed. Elsevier; 2017.
- Kaushansky K, et al. Williams Hematology. 10th ed. McGraw-Hill; 2021.
- Rifai N, Horvath AR, Wittwer CT, eds. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 6th ed. Elsevier; 2018.
CLSI and Professional Guidelines
- Clinical and Laboratory Standards Institute. Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline. CLSI document H21-A5. CLSI; 2017.
- Clinical and Laboratory Standards Institute. One-Stage Prothrombin Time (PT) Test and Partial Thromboplastin Time (PTT) Test; Approved Guideline. CLSI document H47-A2. CLSI; 2008.
- Clinical and Laboratory Standards Institute. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Standard. CLSI document EP28-A3c. CLSI; 2010.
- Clinical and Laboratory Standards Institute. Management of Critical- and Significant-Risk Results. CLSI guideline GP47-Ed1. CLSI; 2015.
Frequently Asked Questions
Common questions about using this Activated Partial Thromboplastin Time (aPTT) laboratory test Medical Laboratory Library reference in Medical Laboratory Science education.
What is the Activated Partial Thromboplastin Time (aPTT) laboratory test reference used for?
This Medical Laboratory Library page summarizes the clinical importance of Activated Partial Thromboplastin Time (aPTT). Review the Clinical Importance section for why the test is ordered in laboratory medicine practice.
Where can I find Activated Partial Thromboplastin Time (aPTT) specimen requirements?
See the Specimen Requirements section on this page for specimen information related to Activated Partial Thromboplastin Time (aPTT). Confirm collection details against your laboratory protocol.
Where are Activated Partial Thromboplastin Time (aPTT) reference values listed?
See the Reference Values section on this Laboratory Library page. Reference ranges can vary by method and population, so verify intervals with your laboratory.
How do I interpret Activated Partial Thromboplastin Time (aPTT) results?
Use the Interpretation section for laboratory interpretation framing, including increased and decreased result patterns when provided. Do not treat educational text as a patient-specific diagnosis.
What analytical method is used for Activated Partial Thromboplastin Time (aPTT)?
See the Analytical Method section for principle and method notes. Method details may differ by instrument and institutional SOP.
Are related laboratory tests linked from Activated Partial Thromboplastin Time (aPTT)?
Yes. The Related Laboratory Tests section lists connected references for continued lookup in the Medical Laboratory Library.
How can I continue learning after reading Activated Partial Thromboplastin Time (aPTT)?
Use Continue learning links on this page for related Academy lessons, medical laboratory quizzes, or laboratory case studies when available for this Hematology topic.
What are the clinical pearls for Activated Partial Thromboplastin Time (aPTT)?
See the Clinical Pearls section for concise laboratory practice notes associated with Activated Partial Thromboplastin Time (aPTT). Apply pearls alongside institutional protocols.
Reading progress
Awards XP once after you have meaningfully reviewed this article.